Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [4, 3 -a] quinoline derivatives as potent anticonvulsants

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 10, Issue 3, 2007, Pages 254-262

  Guan, Li Ping ^a   Jin, Qing Hao ^a   Tian, Guan Rong ^a   Chai, Kyu Yun ^b   Quan, Zhe Shan ^a  

^a YANBIAN UNIVERSITY   (China)

^b Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 FLUOROPHENYL) 3,4 DIHYDRO 2(1H) QUINOLONE; 4 (4 CHLOROPHENYL) 3,4 DIHYDRO 2(1H) QUINOLONE; 4 (4 FLUOROPHENYL) 3,4 DIHYDRO 2(1H) QUINOLONE; 4 (4 METHOXYPHENYL) 3,4 DIHYDRO 2(1H) QUINOLONE; 4 (4 METHYLPHENYL) 3,4 DIHYDRO 2(1H) QUINOLONE; 4 PHENYL 3,4 DIHYDRO 2(1H) QUINOLONE; 5 (3 FLUOROPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLIN 1(2H) ONE; 5 (3 FLUOROPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLINE; 5 (4 CHLOROPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLIN 1(2H) ONE; 5 (4 CHLOROPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLINE; 5 (4 FLUOROPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLIN 1(2H) ONE; 5 (4 FLUOROPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLINE; 5 (4 METHOXYPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLIN 1(2H) ONE; 5 (4 METHOXYPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLINE; 5 (4 METHYLPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLIN 1(2H) ONE; 5 (4 METHYLPHENYL) 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLINE; 5 PHENYL 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLIN 1(2H) ONE; 5 PHENYL 4,5 DIHYDRO 1,2,4 TRIAZOLO[4,3 A]QUINOLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC SHOCK; MOUSE; NEUROTOXICITY; NONHUMAN;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTROSHOCK; EPILEPSY; MICE; MICE, INBRED C57BL; NEUROTOXICITY SYNDROMES; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34447508262     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Loscher, W. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol, 342 (1): 1-13, 1998.
2. Leppik, I. E. Antiepileptic drugs in development: prospects for the near future. Epilepsia, 35 (S4): 29-40, 1994.
3. Al-Soud, Y. A., Al-Masoudi, N. A., Ferwanah, Ael-R. Synthesis and properties of new substituted 1,2,4-triazoles: potential antitumor agents. Bioorg. Med. Chem, 11: 1701-1708, 2003.
4. Joseph, B., Darro, F., Behard, A., Lesur, B., Collignon, F., Decaestecker, C., Frydman, A., Guillaumet, G., Kiss, R. 3-Aryl-2-quinolone derivatives: synthesis and characterization of in vitro and in vivo anti- tumor effects with emphasis on a new therapeutical target connected with cell migration. J.Med.Chem, 45: 2543-2555, 2002.
5. Xiao, Z., Waters, N. C., Woodard, C. L., Li, p. K. Design and synthesis of pfmrk inhibitors as potential antimalarial agents. Bioorg. Med. Chem. Lett, 11: 2875-2878, 2001.
6. Nishi, T., Kimura, Y., Nakagawa, K. Research and development of cilostazol: An antiplatelet agent. Yaku-gaku. Zasshi, 120: 1247-1260, 2000.
7. Oshiro, Y., Sakurai, Y., Sato, S., Kurahashi, N., Tanaka, T., Kikuchi, T., Tottori, K., Uwahodo, Y., Miwa,T., Nishi, T. 3,4-Dihydro-2(1H) quinolinone as a novel antidepressant drug: Synthesis and pharmacology of 1-[3-[4-(3 chlorophenyl)-1-piperazinyl]propyl]-3,4 dihydro-5-methoxy-2(1H)-quinolinone and Its Derivatives. J. Med. Chem, 43: 177-189, 2000.
8. Banno, K., Fujioka, T., kikuchi, T., Oshiro, Y., Hiyama, T., Nakagawa, K. Studies on 2(1H)-uinolinonederivatives as neuroleptic agents I. Synthesis and biological activities of (4-phenyl-1-iperazinyl)-propoxy-2(1H)-quinolinone derivatives. Chem.Pharm.Bull, 36: 4377-4388. 1988.
9. Bell, A. S., Campbell, S. F., Roberts, D. A., Ruddock, K. S. 7-Heteroaryl-1,2,3,5-tetrahydroimidazol[2,1-b]quinazolin-2(1H)-one derivatives with cardiac stimulant activity. J. Med. Chem, 32: 2042-2049, 1989.
10. Piao, H. R., Quan, Z. S., Xu, M. X., Deng, D. W. Synthesis and positive inotropic activities of 3,4-dihydro-6-(4-substituted-1-piperazinylacetamino)-2(1H)-quinolinone derivatives. Chin. J. Med. Chem, 9: 79-83, 1999.
11. Chimirri, A., De Sarro, G., De Sarro, A., Gitto, R., Grasso, S., Quartarone, S., Zappala, M., giusti, P., Libri, V., Constanti, A., Chapman, A. G. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists. J. Med. Chem, 40: 1258-1269, 1997.
12. Gitto, R., Orlando, V., Quartarone, S., De Sarro, G., De Sarro, A., Russo, E., Ferreri, G., Chimirri, A. Synthesis and evaluation of pharmacogogical properties of novel annelated 2,3-benzodiazepine derivatives. J. Med. Chem, 46: 3758-3761, 2003.
13. Zappala, M., Gitto, R., Bevacqua, F., Quartarone, S., Chimirri, A., Rizzo, M., De Sarro, G., De Sarro, A. Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]-triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones. J. Med. Chem, 43: 4834-4839, 2000.
14. Chimirri, A., Bevacqua, F., Gitto, R., Quartarone, S., Zappala. M., De Sarro, A., Maciocco, L., Biggo, G., De Sarro, G. Synthesis and anticonvulsant activity of new 11H-triazolo[4,5-c][2,3]benzodiaze-pines. Med. Chem. Res, 9: 203-212, 1999.
15. Johnston, K. M. Friedel-crafts cyclizations-I: The influence of nuclear substituents on the polyphosphoric acid-catalysed isomerization of cinnamanilide to 4-phenyl-3,4-dihydrocarbostyril. Tetrahedron, 24: 5595-5560, 1968.
16. Xie, Z. F., Chai, K. Y., Piao, H. R., Kwak, K. C., Quan, Z. S. Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines. Bioorg. Med. Chem Lett, 15: 4803-4805, 2005.
17. Cui, L. J., Xie, Z. F., Piao, H. R., Li, G., Chai, K. Y., Quan, Z. S. Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline. Biol. Pharm. Bull, 28: 1216-1220, 2005.
18. Krall, R. J., Penry, J. K., White, B. G., Kupferberg, H. J. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia, 19: 409-428, 1978.
19. Poter, R. J., Cereghino, J. J., Gladding, G. D., Hessie, B. J., Kupferberg, H. J., Scoville, B. Antiepileptic drug development program. Clev. Clin. J. Med, 51: 293-305, 1984.
20. Okada, R., Negishi, H. The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazole-induced seizures. Brain Res, 480: 383-387, 1989.
21. De, Sarro, A., Cechetti, V., Fravolini, V., Naccari, F., Tabarini, O., De, Sarro, G. Effects of novel desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice. Antimicrob Agents Chemother, 43: 1729-1736, 1999.
22. Meldrum, BS. Epilepsy and gamma-aminobutyric acid-induced inhibition. Int. Rev. Neurobiol, 17:1-36, 1975.
23. Olsen, RWJ. GABA-benzodiazepine-barbiturate receptor interaction. J. Neurochem, 27: 1-3, 1981.
24. Gale, K. GABA and epilepsy: Basic concepts from preclinical research. Epelepsia, 33: S3-S12, 1992.